4 Results for "

UVRAG

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "UVRAG" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-156237
CAS No.: 1243063-73-1
Purity:  99.88%
Target:  

Autophagy

Research Areas:  

Others

Beclin1-ATG14L interaction inhibitor 1 (com 19) is a selective Beclin1-ATG14L interaction inhibitor. This protein interaction mechanism specifically targets complex I of the lipid kinase VPS34 without affecting complex II. Because the integrity of VPS34 complex II depends on the Beclin 1-UVRAG interaction. Beclin1-ATG14L interaction inhibitor 1 can disrupt the formation of VPS34 complex I and inhibit autophagy, but does not affect complex II-related vesicle transport .
loading...
    loading...
Cat. No.: HY-152100
CAS No.: 1370032-20-4
Purity:  98.69%
Target:  

Autophagy

Research Areas:  

Cancer

CUR5g is a potent autophagy inhibitor. CUR5g selectively inhibits autophagosome degradation in cancer cells by blocking autophagosome-lysosome fusion. CUR5g blocks the recruitment of STX17 to autophagosomes via a UVRAG-dependent mechanism, resulting in the inability of autophagosomes to fuse with lysosomes. CUR5g improves the anticancer effect of Cisplatin (HY-17394) against A549 cells both in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-RS15588
Research Areas:  

Others

UVRAG Human Pre-designed siRNA Set A contains three designed siRNAs for UVRAG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-183987
CAS No.: 859138-65-1
Research Areas:  

Cancer

ZINC000002107582 is a UVRAG binder. ZINC000002107582 induces Apoptosis, increases intracellular ROS levels, arrests the cell cycle at the S phase, and elevates the proportion of cells in the Sub G0 phase. ZINC000002107582 exhibits anticancer activity against breast cancer .
loading...
    loading...